{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T22:28:05Z","timestamp":1767220085709,"version":"3.28.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T00:00:00Z","timestamp":1685923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T00:00:00Z","timestamp":1685923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>EAU guidelines strongly recommend kidney sparing surgery (KSS) as the primary treatment option for the low-risk UTUC patients. While there are few reports involving the KSS treated for the high-risk counterparts, especially the ureteral resection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To evaluate the effectiveness and safety of the segmental ureterectomy (SU) for the patients with high-risk ureteral carcinoma.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>We included 20 patients from May 2017 to December 2021 who underwent segmental ureterectomy (SU) in Henan Provincial People\u2019s Hospital. The overall survival (OS) and progression free survival (PFS) were evaluated. Besides, the ECOG scores and postoperative complications were also included.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>As of December 2022, the mean OS was 62.1months (95%CI:55.6-68.6months) and the mean PFS was 45.0months (95%CI:35.9-54.1months). The median OS and median PFS were not reached. The 3-year OS rate was 70% and the 3-year PFS rate was 50%. The percentage of Clavien I and II complications was 15%.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>For the selected patients with high-risk ureteral carcinoma, the efficacy and safety of segmental ureterectomy were satisfactory. But we still need to conduct prospective or randomized study to validate the value of SU in patients with high-risk ureteral carcinoma.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12894-023-01265-y","type":"journal-article","created":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T17:02:10Z","timestamp":1685984530000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Segmental ureterectomy for high-risk ureteral carcinoma: a preliminary report"],"prefix":"10.1186","volume":"23","author":[{"given":"Wei","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingdian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyu","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Degang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,5]]},"reference":[{"issue":"1","key":"1265_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD,Fuchs HE,Jemal A. Cancer statistics,2022.CA. Cancer J Clin. 2022;72(1):7\u201333.","journal-title":"Cancer J Clin"},{"issue":"1","key":"1265_CR2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.eururo.2020.05.042","volume":"79","author":"M Roupret","year":"2021","unstructured":"Roupret M, Babjuk M, Burger M, Capoun O,Cohen, D,Comp\u00e9rat. EM,et al:European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2020 update. Eur Urol. 2021;79(1):62\u201379.","journal-title":"Eur Urol"},{"issue":"6","key":"1265_CR3","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.eururo.2016.07.014","volume":"70","author":"T Seisen","year":"2016","unstructured":"Seisen T, Peyronnet B, Dominguez-Escrig JL, Bruins HM, Yuan CY,Babjuk. M,et al:oncologic outcomes of kidney-sparing surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: a systematic review by the EAU non-muscle invasive bladder Cancer Guidelines Panel. Eur Urol. 2016;70(6):1052\u201368.","journal-title":"Eur Urol"},{"issue":"4","key":"1265_CR4","first-page":"359","volume":"68","author":"JD Raman","year":"2016","unstructured":"Raman JD. Kidney sparing surgery for upper-tract urothelial carcinoma. Minerva Urol Nefrol. 2016;68(4):359\u201371.","journal-title":"Minerva Urol Nefrol"},{"key":"1265_CR5","doi-asserted-by":"publisher","unstructured":"Coll\u00e0 Ruvolo C, W\u00fcrnschimmel C, Wenzel M, Nocera L, Califano G, Tian Z, Shariat SF. Comparison between 1973 and 2004\/2016 WHO grading systems in patients with Ta urothelial carcinoma of urinary bladder. J Clin Pathol 2022 May;75(5):333\u20137. doi: https:\/\/doi.org\/10.1136\/jclinpath-2021-207400. Epub 2021 Feb 23.","DOI":"10.1136\/jclinpath-2021-207400"},{"key":"1265_CR6","doi-asserted-by":"publisher","unstructured":"Coll\u00e0 Ruvolo C, Deuker M, Wenzel M, Nocera L, W\u00fcrnschimmel C, Califano G et al. Impact of the primary tumor location on secondary sites and overall mortality in patients with metastatic upper tract urothelial carcinoma. Urol Oncol. 2022 Sep;40(9): 411.e1-411.e8. doi: https:\/\/doi.org\/10.1016\/j.urolonc.2022.06.009. Epub 2022 Jul 25.","DOI":"10.1016\/j.urolonc.2022.06.009"},{"issue":"6","key":"1265_CR7","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.euf.2018.03.003","volume":"5","author":"M Momota","year":"2019","unstructured":"Momota M, Hatakeyama S, Tokui N, Sato T,Yamamoto H,Tobisawa. Y,et al:the impact of preoperative severe renal insufficiency on poor postsurgical oncological prognosis in patients with urothelial carcinoma. Eur Urol Focus. 2019;5(6):1066\u201373.","journal-title":"Eur Urol Focus"},{"issue":"10232","key":"1265_CR8","first-page":"1268","volume":"395","author":"A Birtle","year":"2020","unstructured":"Birtle A, Johnson M, Chester J, Jones, R,Dolling D,Bryan. RT,et al:adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label. randomised controlled trial Lancet. 2020;395(10232):1268\u201377.","journal-title":"randomised controlled trial Lancet"},{"key":"1265_CR9","unstructured":"Coleman JA. Yip W,Wong NC,Sjoberg DD,Bochner BH,Dalbagni G,:Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients with High-Grade Upper Tract Urothelial Carcinoma.J Clin Oncol.2023; JCO2200763."},{"issue":"4","key":"1265_CR10","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1464-410X.2012.11649.x","volume":"112","author":"E Xylinas","year":"2013","unstructured":"Xylinas E, Rink M, Margulis V, Clozel T, Lee RK,Comploj. E,et al:impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy. Bju Int. 2013;112(4):453\u201361.","journal-title":"Bju Int"},{"issue":"11","key":"1265_CR11","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/j.ejso.2016.08.008","volume":"42","author":"D Fang","year":"2016","unstructured":"Fang D, Seisen T, Yang K,Liu P,Fan X,Singla. N,et al:a systematic review and meta-analysis of oncological and renal function outcomes obtained after segmental ureterectomy versus radical nephroureterectomy for upper tract urothelial carcinoma. Ejso-Eur J Sug Onc. 2016;42(11):1625\u201335.","journal-title":"Ejso-Eur J Sug Onc"},{"key":"1265_CR12","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.euros.2022.04.007","volume":"40","author":"N Hendriks","year":"2022","unstructured":"Hendriks N, Baard J, Beerlage HP,Schout BMA. Doherty KSG,Pelger RCM,et al:Survival and Long-term Effects of kidney-sparing surgery Versus Radical Nephroureterectomy on kidney function in patients with Upper urinary tract Urothelial Carcinoma. Eur Urol Open Sci. 2022;40:104\u201311.","journal-title":"Eur Urol Open Sci"},{"key":"1265_CR13","doi-asserted-by":"crossref","unstructured":"Shen CY. Jou YC,Kan WC,Tzai TS,Tsai YS:Outcome of Non-Muscle Invasive Upper Tract Urothelial Carcinoma Receiving Endoscopic Ablation: An Inverse Probability of Treatment Weighting Analysis.J Clin Med.2022;11(5)","DOI":"10.3390\/jcm11051307"},{"key":"1265_CR14","doi-asserted-by":"crossref","unstructured":"Coll\u00e0 Ruvolo C, Nocera L, Stolzenbach LF, Wenzel M, Califano G, Tian Z, et al. Tumor size predicts muscle-invasive and non-organ-confined disease in Upper Tract Urothelial Carcinoma at Radical Nephroureterectomy. Eur Urol Focus. 2022 Mar;8(2):498\u2013505.","DOI":"10.1016\/j.euf.2021.03.003"},{"issue":"4","key":"1265_CR15","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.eururo.2021.05.004","volume":"80","author":"B Foerster","year":"2021","unstructured":"Foerster B, Abufaraj M, Matin SF,Azizi M,Gupta M, Li. WM,et al:pretreatment risk stratification for endoscopic kidney-sparing surgery in Upper Tract Urothelial Carcinoma: An International Collaborative Study. Eur Urol. 2021;80(4):507\u201315.","journal-title":"Eur Urol"},{"key":"1265_CR16","doi-asserted-by":"crossref","unstructured":"Shishido SN, Ghoreifi A, Sayeed S, Courcoubetis G,Huang A,Ye B et al. Liquid Biopsy Landscape in Patients with Primary Upper Tract Urothelial Carcinoma.Cancers (Basel).2022;14(12).","DOI":"10.3390\/cancers14123007"},{"issue":"5","key":"1265_CR17","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.juro.2015.11.036","volume":"195","author":"T Seisen","year":"2016","unstructured":"Seisen T, Nison L,Remzi M, Klatte T, Mathieu R,Lucca. I,et al:oncological outcomes of radical nephroureterectomy versus kidney-sparing surgery for elective treatment of clinically organ-confined upper tract urothelial carcinoma of the distal ureter. J Urol. 2016;195(5):1354\u201361.","journal-title":"J Urol"},{"key":"1265_CR18","doi-asserted-by":"publisher","unstructured":"Peyrottes A, Califano G, Ouza\u00efd I, Lain\u00e9-Caroff P, Long Depaquit T, Hermieu JF et al. Lymph Node Dissection During Radical Nephro-Ureterectomy for Upper Tract Urothelial Carcinoma: A Review. Front Surg 2022 Mar 24; 9:852969. doi: https:\/\/doi.org\/10.3389\/fsurg.2022.852969.","DOI":"10.3389\/fsurg.2022.852969"},{"key":"1265_CR19","doi-asserted-by":"crossref","unstructured":"Panos G, Mulita F, Akinosoglou K, Liolis E, Kaplanis C, Tchabashvili L et al. Risk of surgical site infections after colorectal surgery and the most frequent pathogens isolated: a prospective single-centre observational study. Med Glas (Zenica). 2021 Aug 1;18(2):438\u2013443.","DOI":"10.17392\/1348-21"},{"issue":"1","key":"1265_CR20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11377-021-00584-6","volume":"17","author":"F Mulita","year":"2022","unstructured":"Mulita F, Liolis E, Akinosoglou K, Tchabashvili L, Maroulis I, Kaplanis C, et al. Postoperative sepsis after colorectal surgery: a prospective single-center observational study and review of the literature. Prz Gastroenterol. 2022;17(1):47\u201351.","journal-title":"Prz Gastroenterol"},{"key":"1265_CR21","doi-asserted-by":"crossref","unstructured":"Masson-Lecomte A, Vaillant V,Roumigui\u00e9 M,L\u00e9vy, S,Prad\u00e8re B,Peyromaure. M,:Oncological Outcomes of Distal Ureterectomy for High-Risk Urothelial Carcinoma: A Multicenter Study by The French Bladder Cancer Committee.Cancers (Basel).2022;14(21).","DOI":"10.3390\/cancers14215452"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-023-01265-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-023-01265-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-023-01265-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T20:33:42Z","timestamp":1729542822000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-023-01265-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,5]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1265"],"URL":"https:\/\/doi.org\/10.1186\/s12894-023-01265-y","relation":{},"ISSN":["1471-2490"],"issn-type":[{"type":"electronic","value":"1471-2490"}],"subject":[],"published":{"date-parts":[[2023,6,5]]},"assertion":[{"value":"28 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study was conducted in accordance with the Declaration of Helsinki (as revised in 2013) and was approved by the Institutional Review Board of Henan Provincial People\u2019s Hospital, which waived the requirement of informed consent for this retrospective analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"103"}}